Holen Sie sich die Stockscreener-App
11.57
4.97%
0.51
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
CorMedix Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - Autocar Professional
What drives CorMedix Inc. stock priceExceptional ROI - Autocar Professional
What analysts say about CorMedix Inc. stockMassive portfolio appreciation - jammulinksnews.com
Is CorMedix Inc. a good long term investmentUnmatched market performance - Autocar Professional
CorMedix Inc. (CRMD) Plunges 1.90% to 2025 Low - AInvest
Why CorMedix Inc. stock attracts strong analyst attentionFree Access to Community - Newser
What makes CorMedix Inc. stock price move sharplyFree Consultation - Newser
How CorMedix Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser
CorMedix soars on increased Q2 sales guidance - MSN
Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive? - Yahoo Finance
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study - TipRanks
(CRMD) Investment Analysis and Advice - news.stocktradersdaily.com
Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18 - 富途牛牛
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
CorMedix Completes $82.2 Million Stock Offering - The Globe and Mail
CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com
CorMedix stock rating reiterated as Buy by H.C. Wainwright - Investing.com India
CorMedix slides after pricing $85M stock offering - MSN
CorMedix prices $85 million public offering of common stock By Investing.com - Investing.com South Africa
CorMedix Stock Tumbles After $85M Stock Sale; But Retail Sees Bargain In DefenCath Bet - Asianet Newsable
CorMedix plans $85 million common stock offering - Investing.com India
CorMedix stock falls after $85 million share offering announcement - Investing.com
CorMedix stock falls after $85 million share offering announcement By Investing.com - Investing.com UK
CorMedix shareholders approve board nominees and key proposals at annual meeting - Investing.com
CorMedix stock rises as Truist reiterates buy on expanded DefenCath rollout - Investing.com Canada
CorMedix Lifts Q2 Outlook As Dialysis Partner Expands DefenCath Use; Needham Raises PT To $20 - Stocktwits
CorMedix inc. Announces Customer Implementation - The Manila Times
CorMedix (CRMD) Target Price Increased by Needham Following Positive Update | CRMD Stock News - GuruFocus
Cormedix (CRMD) Receives a Rating Update from a Top Analyst - The Globe and Mail
CorMedix price target raised to $17 from $13 at RBC Capital - TipRanks
Learn to Evaluate (CRMD) using the Charts - news.stocktradersdaily.com
CorMedix stock price target raised to $17 from $13 at RBC Capital - Investing.com
CorMedix Inc.'s (NASDAQ:CRMD) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Despite shrinking by US$64m in the past week, CorMedix (NASDAQ:CRMD) shareholders are still up 366% over 3 years - simplywall.st
CorMedix stock rises after earnings, revenue beat - MSN
CorMedix stock soars to 52-week high, hits $15.33 By Investing.com - Investing.com South Africa
4.56%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):